Published in Br J Pharmacol on August 02, 2004
Nitric oxide and peroxynitrite in health and disease. Physiol Rev (2007) 15.49
Direct impairment of vascular function by diesel exhaust particulate through reduced bioavailability of endothelium-derived nitric oxide induced by superoxide free radicals. Environ Health Perspect (2008) 1.25
A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations. Br J Pharmacol (2005) 0.87
GEA 3162, a peroxynitrite donor, induces Bcl-2-sensitive, p53-independent apoptosis in murine bone marrow cells. Biochem Pharmacol (2007) 0.82
Effect of wood smoke exposure on vascular function and thrombus formation in healthy fire fighters. Part Fibre Toxicol (2014) 0.79
Cyclic GMP protects human macrophages against peroxynitrite-induced apoptosis. J Inflamm (Lond) (2009) 0.78
Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agents. Bioorg Med Chem (2013) 0.75
Shape-Related Toxicity of Titanium Dioxide Nanofibres. PLoS One (2016) 0.75
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 40.02
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 35.44
Complexes of .NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem (1991) 3.27
Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem (1997) 2.89
Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J (1992) 2.51
Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: implications for intracellular measurement of reactive nitrogen and oxygen species. Nitric Oxide (1997) 2.11
NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro. J Biol Chem (1999) 1.89
The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock (1996) 1.78
Nitric oxide as a bifunctional regulator of apoptosis. Circ Res (1999) 1.63
Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide (1997) 1.33
The nitric oxide/superoxide assay. Insights into the biological chemistry of the NO/O-2. interaction. J Biol Chem (1997) 1.26
Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem J (1996) 1.24
Further characterization of the neutrophil oxidative burst by flow cytometry. J Immunol Methods (1993) 1.19
Spin trapping of superoxide radicals and peroxynitrite by 1-hydroxy-3-carboxy-pyrrolidine and 1-hydroxy-2,2,6, 6-tetramethyl-4-oxo-piperidine and the stability of corresponding nitroxyl radicals towards biological reductants. Biochem Biophys Res Commun (1997) 1.11
Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets. Trends Pharmacol Sci (1999) 1.03
Nitric oxide: a key regulator of myeloid inflammatory cell apoptosis. Cell Death Differ (2003) 1.03
Inhibition by antioxidants of nitric oxide synthase expression in murine macrophages: role of nuclear factor kappa B and interferon regulatory factor 1. Br J Pharmacol (1996) 1.02
Induction of human neutrophil apoptosis by nitric oxide donors: evidence for a caspase-dependent, cyclic-GMP-independent, mechanism. Biochem Pharmacol (2000) 0.98
The cardiovascular effects and implications of peroxynitrite. Cardiovasc Res (1999) 0.96
The effect of nitric oxide and peroxynitrite on apoptosis in human polymorphonuclear leukocytes. Free Radic Biol Med (1998) 0.94
Radical releasing properties of nitric oxide donors GEA 3162, SIN-1 and S-nitroso-N-acetylpenicillamine. Eur J Pharmacol (1998) 0.93
The DFF40/CAD endonuclease and its role in apoptosis. Acta Biochim Pol (2000) 0.92
Dissociation of DNA fragmentation from other hallmarks of apoptosis in nitric oxide-treated neutrophils: differences between individual nitric oxide donor drugs. Biochem Biophys Res Commun (2001) 0.91
Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives. Br J Pharmacol (1996) 0.89
Activation of neutrophil function via CD66: differential effects upon beta 2 integrin mediated adhesion. Br J Haematol (1997) 0.86
Novel role for low molecular weight plasma thiols in nitric oxide-mediated control of platelet function. J Biol Chem (2002) 0.86
The role of protein nitration in the inhibition of platelet activation by peroxynitrite. FEBS Lett (2002) 0.84
Nitric oxide: an endogenous gas. Br J Anaesth (1995) 0.81
Nitration/S-nitrosation of proteins by peroxynitrite-treatment and subsequent modification by glutathione S-transferase and glutathione peroxidase. Mol Cell Biochem (2002) 0.78
Effect of intracerebroventricular and intravenous administration of nitric oxide donors on blood pressure and heart rate in anaesthetized rats. Br J Pharmacol (1996) 0.77
Resolution of inflammation: state of the art, definitions and terms. FASEB J (2007) 5.12
Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov (2004) 5.08
Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat Med (2006) 3.79
Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol (2008) 2.83
Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci U S A (2006) 2.75
A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med (2010) 2.72
A randomized controlled trial of peripheral blood mononuclear cell depletion in experimental human lung inflammation. Am J Respir Crit Care Med (2013) 2.71
Persistent endothelial dysfunction in humans after diesel exhaust inhalation. Am J Respir Crit Care Med (2007) 2.65
Enzyme-independent NO stores in human skin: quantification and influence of UV radiation. J Invest Dermatol (2008) 2.36
Regulation of alternative macrophage activation by galectin-3. J Immunol (2008) 2.28
Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am J Respir Crit Care Med (2011) 2.15
Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumonia. Thorax (2009) 1.87
Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol (2007) 1.85
Monocytes control second-phase neutrophil emigration in established lipopolysaccharide-induced murine lung injury. Am J Respir Crit Care Med (2012) 1.82
Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin. J Clin Invest (2008) 1.78
The involvement of the apoptosis-modulating proteins ERK 1/2, Bcl-xL and Bax in the resolution of acute inflammation in vivo. Am J Pathol (2006) 1.74
Topically applied nitric oxide induces T-lymphocyte infiltration in human skin, but minimal inflammation. J Invest Dermatol (2007) 1.68
Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents: key role for TNF-alpha. FASEB J (2008) 1.60
Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. Environ Health Perspect (2010) 1.57
Neutrophil apoptosis: relevance to the innate immune response and inflammatory disease. J Innate Immun (2010) 1.57
Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. Antioxid Redox Signal (2005) 1.54
Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications, and therapeutic opportunities. Antioxid Redox Signal (2008) 1.53
Adhesion molecule-dependent mechanisms regulate the rate of macrophage clearance during the resolution of peritoneal inflammation. J Exp Med (2002) 1.51
The role of the purinergic P2X7 receptor in inflammation. J Inflamm (Lond) (2007) 1.50
Wogonin induces eosinophil apoptosis and attenuates allergic airway inflammation. Am J Respir Crit Care Med (2015) 1.49
Integrin activation by Fam38A uses a novel mechanism of R-Ras targeting to the endoplasmic reticulum. J Cell Sci (2010) 1.45
Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes. Part Fibre Toxicol (2011) 1.38
Cigarette smoke prevents apoptosis through inhibition of caspase activation and induces necrosis. Am J Respir Cell Mol Biol (2003) 1.35
Non-heme iron nitrosyls in biology. Chem Rev (2002) 1.34
From particles to patients: oxidative stress and the cardiovascular effects of air pollution. Future Cardiol (2012) 1.33
Vascular effects of apelin in vivo in man. J Am Coll Cardiol (2008) 1.33
Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages. J Immunol (2009) 1.30
Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions in vitro and in vivo; zinc and copper nanoparticles, but not their ions, recruit eosinophils to the lungs. Nanotoxicology (2011) 1.29
In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humans. Circ Cardiovasc Imaging (2012) 1.29
Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function. Am J Pathol (2008) 1.28
Targeting granulocyte apoptosis: mechanisms, models, and therapies. Immunol Rev (2010) 1.27
The cyclin-dependent kinase inhibitor R-roscovitine down-regulates Mcl-1 to override pro-inflammatory signalling and drive neutrophil apoptosis. Eur J Immunol (2010) 1.26
Direct impairment of vascular function by diesel exhaust particulate through reduced bioavailability of endothelium-derived nitric oxide induced by superoxide free radicals. Environ Health Perspect (2008) 1.25
Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing the resolution of inflammation. Trends Pharmacol Sci (2008) 1.25
The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. J Leukoc Biol (2006) 1.25
The anti-inflammatory effects and the inhibition of neutrophil responsiveness by Barleria lupulina and Clinacanthus nutans extracts. J Ethnopharmacol (2007) 1.23
Mammalian NOTCH-1 activates beta1 integrins via the small GTPase R-Ras. J Biol Chem (2007) 1.23
CD98hc (SLC3A2) interaction with beta 1 integrins is required for transformation. J Biol Chem (2004) 1.22
Macrophage phagocytosis of apoptotic neutrophils is compromised by matrix proteins modified by cigarette smoke and lipid peroxidation products. Biochem Biophys Res Commun (2004) 1.21
Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. Am J Respir Cell Mol Biol (2008) 1.19
Expression of the developmental Sonic hedgehog (Shh) signalling pathway is up-regulated in chronic lung fibrosis and the Shh receptor patched 1 is present in circulating T lymphocytes. J Pathol (2003) 1.17
Resolution of inflammation: mechanisms and opportunity for drug development. Pharmacol Ther (2013) 1.15
Exceptional behavior over the whole adsorption-storage-delivery cycle for NO in porous metal organic frameworks. J Am Chem Soc (2008) 1.14
Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal oxide nanoparticles. Toxicol Sci (2012) 1.14
Phosphoinositide-3 kinases critically regulate the recruitment and survival of eosinophils in vivo: importance for the resolution of allergic inflammation. J Leukoc Biol (2005) 1.14
Increased virulence of a fibronectin-binding protein mutant of Staphylococcus aureus in a rat model of pneumonia. Infect Immun (2002) 1.10
Mechanisms of resolution of inflammation: a focus on cardiovascular disease. Arterioscler Thromb Vasc Biol (2011) 1.10
Anti-interleukin-8 autoantibodies in patients at risk for acute respiratory distress syndrome. Crit Care Med (2002) 1.07
Heme inhibits human neutrophil apoptosis: involvement of phosphoinositide 3-kinase, MAPK, and NF-kappaB. J Immunol (2004) 1.06
Phagocytosis of apoptotic cells by human macrophages: analysis by multiparameter flow cytometry. Cytometry A (2003) 1.06
Phagocytosis of apoptotic cells. Methods (2008) 1.05
Cross-linking CD98 promotes integrin-like signaling and anchorage-independent growth. Mol Biol Cell (2002) 1.04
Inhibition of nuclear factor-kappaB activation un-masks the ability of TNF-alpha to induce human eosinophil apoptosis. Eur J Immunol (2002) 1.02
C5a mediates peripheral blood neutrophil dysfunction in critically ill patients. Am J Respir Crit Care Med (2009) 1.01
Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents. J Immunol (2002) 1.01
NO-releasing zeolites and their antithrombotic properties. J Am Chem Soc (2006) 1.00
C5a-mediated neutrophil dysfunction is RhoA-dependent and predicts infection in critically ill patients. Blood (2011) 0.98
Decidual neutrophil infiltration is not required for preterm birth in a mouse model of infection-induced preterm labor. J Immunol (2014) 0.98
The CDK inhibitor, R-roscovitine, promotes eosinophil apoptosis by down-regulation of Mcl-1. FEBS Lett (2009) 0.98
Tissue- and stimulus-dependent role of phosphatidylinositol 3-kinase isoforms for neutrophil recruitment induced by chemoattractants in vivo. J Immunol (2007) 0.96
E-selectin permits communication between PAF receptors and TRPC channels in human neutrophils. Blood (2006) 0.96
Effects of glucocorticoids on apoptosis and clearance of apoptotic cells. ScientificWorldJournal (2007) 0.96
Predictive value of in vitro assays depends on the mechanism of toxicity of metal oxide nanoparticles. Part Fibre Toxicol (2013) 0.96
PDE4 inhibition drives resolution of neutrophilic inflammation by inducing apoptosis in a PKA-PI3K/Akt-dependent and NF-kappaB-independent manner. J Leukoc Biol (2010) 0.95
Col4a1 mutation in mice causes defects in vascular function and low blood pressure associated with reduced red blood cell volume. Hum Mol Genet (2010) 0.94
Oxygen levels determine the ability of glucocorticoids to influence neutrophil survival in inflammatory environments. J Leukoc Biol (2013) 0.93
Golgi fragmentation during Fas-mediated apoptosis is associated with the rapid loss of GM130. Biochem Biophys Res Commun (2004) 0.93
Secondary necrosis of apoptotic neutrophils induced by the human cathelicidin LL-37 is not proinflammatory to phagocytosing macrophages. J Leukoc Biol (2009) 0.93
Flavones induce neutrophil apoptosis by down-regulation of Mcl-1 via a proteasomal-dependent pathway. FASEB J (2012) 0.93
Xanthohumol induces apoptosis in human malignant glioblastoma cells by increasing reactive oxygen species and activating MAPK pathways. J Nat Prod (2011) 0.93
Nanoparticles and the cardiovascular system: a critical review. Nanomedicine (Lond) (2013) 0.92
Anti-inflammatory mediators as physiological and pharmacological regulators of parturition. Expert Rev Clin Immunol (2011) 0.91
Sildenafil offers protection against NSAID-induced gastric injury. Br J Pharmacol (2005) 0.91
Altered nitric oxide bioavailability contributes to diesel exhaust inhalation-induced cardiovascular dysfunction in man. J Am Heart Assoc (2013) 0.90